United States

Profile: Bio Rad Laboratories Inc (BIO.N)

BIO.N on New York Stock Exchange

12:00pm EDT
Change (% chg)

$0.71 (+0.32%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Bio-Rad Laboratories, Inc. (Bio-Rad), incorporated on March 10, 1975, is a manufacturer and distributor of its life science research and clinical diagnostics products. The Company operates through two segments: Life Science and Clinical Diagnostics. The Company manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Company's Life Science segment develops, manufactures, sells and services reagents, apparatus and instruments used for biological research. The Company's Clinical Diagnostics segment develops, manufactures, sells and services automated test systems, informatics systems, test kits and specialized quality controls for the healthcare market. As of December 31, 2016, Bio-Rad sold more than 8,000 products and services to a client base, including scientific research, healthcare, education and government customers around the world.

Life Science

The Company's Life Science segment markets and develops, manufactures and markets a range of over 5,000 reagents, apparatus and laboratory instruments that serve a global customer base. Its products are used in established research techniques, biopharmaceutical production processes and food testing regimes. These techniques are used to separate, purify and identify biological materials, such as proteins, nucleic acids and bacteria within a laboratory or production setting. The Company focuses on selected segments of the life sciences market in proteomics (the study of proteins), genomics (the study of genes), biopharmaceutical production, cell biology and food safety. Its life science customers include universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers and food testing laboratories.

Clinical Diagnostics

The Company's Clinical Diagnostics segment offers products that serve clinical laboratories in the global diagnostics market. Its products address the in vitro diagnostics (IVD) test market. As of December 31, 2016, the Company sold more than 3,000 different products that cover more than 300 clinical diagnostic tests to the IVD test market. IVD tests are conducted outside the human body and are used to identify and measure substances in a patient's tissue, blood or urine. The Company's products consist of reagents, instruments and software, typically provided to its customers as an integrated package to allow them to generate reproducible test results. Its principal clinical diagnostic customers include hospital laboratories, reference laboratories, transfusion laboratories and physician office laboratories.

The Company competes with GE Biosciences, Merck Millipore, Thermo Fisher Scientific, Roche, Abbott Laboratories, Siemens, Danaher, Becton Dickinson, bioMerieux, Ortho Clinical Diagnostics, Tosoh, Immucor and DiaSorin.

Company Address

Bio Rad Laboratories Inc

HERCULES   CA   94547-1811
P: +1510.7247000
F: +1510.7415817

Company Web Links